Amphotericin versus Fluconazole in Cryptococcal Meningitis

Jonathan P. Tolins, B. Dupont, G. Pialoux, Francesco Menichetti, Carlo Tascini, Michael S. Saag, William G. Powderly, Gretchen A. Cloud, William E. Dismukes

Research output: Contribution to journalLetter

3 Scopus citations

Abstract

To the Editor: Saag et al. (Jan. 9 issue)1 compared intravenous amphotericin B with oral fluconazole in the treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome (AIDS). The data reported indicate that patients treated with amphotericin B fared better, albeit not significantly so, in terms of the success rate of treatment, mortality (especially early mortality), length of time to sterilization of the cerebrospinal fluid, and disease progression. Despite these results, the authors conclude that fluconazole is an effective alternative to amphotericin B in cryptococcal meningitis because of the advantages of oral therapy and the lack of significant differences…

Original languageEnglish
Pages (from-to)1567-1569
Number of pages3
JournalNew England Journal of Medicine
Volume326
Issue number23
DOIs
StatePublished - Jun 4 1992
Externally publishedYes

Fingerprint Dive into the research topics of 'Amphotericin versus Fluconazole in Cryptococcal Meningitis'. Together they form a unique fingerprint.

  • Cite this

    Tolins, J. P., Dupont, B., Pialoux, G., Menichetti, F., Tascini, C., Saag, M. S., Powderly, W. G., Cloud, G. A., & Dismukes, W. E. (1992). Amphotericin versus Fluconazole in Cryptococcal Meningitis. New England Journal of Medicine, 326(23), 1567-1569. https://doi.org/10.1056/NEJM199206043262312